HUP0303007A2 - Új vegyületek HIV proteáz inhibitorként történő felhasználásra és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Új vegyületek HIV proteáz inhibitorként történő felhasználásra és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0303007A2 HUP0303007A2 HU0303007A HUP0303007A HUP0303007A2 HU P0303007 A2 HUP0303007 A2 HU P0303007A2 HU 0303007 A HU0303007 A HU 0303007A HU P0303007 A HUP0303007 A HU P0303007A HU P0303007 A2 HUP0303007 A2 HU P0303007A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- hydrogen atom
- formula
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004415 heterocyclylalkyl group Chemical group 0.000 abstract 2
- -1 2-quinolinecarbonyl Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- QFNGENSDEDFGRJ-UHFFFAOYSA-N bis(phenylmethoxy) carbonate Chemical compound C=1C=CC=CC=1COOC(=O)OOCC1=CC=CC=C1 QFNGENSDEDFGRJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000002895 organic esters Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány (I) általános képletű vegyületekre és azok gyógyászatilagalkalmazható sóira vonatkozik - a képletben R1 hidrogénatomot,hidroxilcsoportot vagy -NHR2 csoportot jelent, ahol az utóbbiképletben R2 hidrogénatomot, alkil-, alkenil-, alkinil-, aril-alkil-,heterociklil-alkil-, cikloalkil-alkil-karbonil-, cikloalkil-karbonil-,aril-karbonil-, heterociklil-karbonil-, heterociklil-alkil-karbonil-,ari-alkil-karbonil-, alkil-oxi-karbonil-, aril-alkil-oxi-karbonil-,heterociklil-alkil-oxi-karbonil-, aril-heterociklil-szulfonil-, alkil-szulfonil-, aril-szulfonil- vagy heterociklil-szulfonil-csoportot vagy(A) vagy (B) általános képletű csoportot jelent; R3 és R4 azonos vagyeltérő alkilcsoportot jelent, vagy a közbezárt szénatommal együttkarbociklusos csoportot alkotnak; R5 alkil-, aril-alkil- vagyheterociklil-alkil-csoportot jelent, vagy R4 és R5 a közbezárt szén-és kénatommal együtt heterociklusos csoportot alkot; R6 alkil-, aril-alkil-, heterociklil-alkil-, alkil-oxi-alkil-, hidroxi-alkil-, amino-alkil vagy fluor-alkil-csoportot jelent; R13 hidrogénatomot vagy egyszervetlen vagy szerves észter maradékát jelenti; és R16 arilcsoportotjelent -; azzal a megszorítással, hogy ha R3, R4 és R5 egyarántmetilcsoportot és R6 terc-butil-csoportot jelent, akkor R13 csakhidrogénatom lehet, és ha R15 fenilcsoportot jelent, akkor R2 csakbenzil-oxi-karbonit- és 2-kinolin-karbonilcsoporttól eltérő lehet. Atalálmány kiterjed a vegyületek felhasználására és ezeket tartalmazógyógyszerkészítményekre. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0028483.6A GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
PCT/EP2001/013068 WO2002042277A1 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0303007A2 true HUP0303007A2 (hu) | 2003-12-29 |
Family
ID=9903670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0303007A HUP0303007A2 (hu) | 2000-11-22 | 2001-11-12 | Új vegyületek HIV proteáz inhibitorként történő felhasználásra és a vegyületeket tartalmazó gyógyszerkészítmények |
Country Status (27)
Country | Link |
---|---|
US (1) | US6472404B1 (hu) |
EP (1) | EP1339692A1 (hu) |
JP (1) | JP2004520283A (hu) |
KR (1) | KR20030060953A (hu) |
CN (1) | CN1476436A (hu) |
AR (1) | AR031763A1 (hu) |
AU (2) | AU2954602A (hu) |
BG (1) | BG107839A (hu) |
BR (1) | BR0115566A (hu) |
CA (1) | CA2428459A1 (hu) |
CZ (1) | CZ20031667A3 (hu) |
EC (1) | ECSP034618A (hu) |
GB (1) | GB0028483D0 (hu) |
GT (1) | GT200100233A (hu) |
HU (1) | HUP0303007A2 (hu) |
IL (1) | IL155573A0 (hu) |
MA (1) | MA26966A1 (hu) |
MX (1) | MXPA03004534A (hu) |
NO (1) | NO20032290D0 (hu) |
NZ (1) | NZ525550A (hu) |
PA (1) | PA8533401A1 (hu) |
PE (1) | PE20020610A1 (hu) |
PL (1) | PL366704A1 (hu) |
RU (1) | RU2265016C2 (hu) |
SK (1) | SK7602003A3 (hu) |
UY (1) | UY27033A1 (hu) |
WO (1) | WO2002042277A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014572B (zh) * | 2004-09-15 | 2011-07-06 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物 |
UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
MY161992A (en) * | 2008-03-26 | 2017-05-31 | Daiichi Sankyo Co Ltd | Novel tetrahydroisoquinoline derivative |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
2000
- 2000-11-22 GB GBGB0028483.6A patent/GB0028483D0/en not_active Ceased
-
2001
- 2001-11-12 AU AU2954602A patent/AU2954602A/xx active Pending
- 2001-11-12 NZ NZ525550A patent/NZ525550A/en unknown
- 2001-11-12 JP JP2002544412A patent/JP2004520283A/ja active Pending
- 2001-11-12 AU AU2002229546A patent/AU2002229546B2/en not_active Ceased
- 2001-11-12 BR BR0115566-0A patent/BR0115566A/pt not_active IP Right Cessation
- 2001-11-12 CN CNA018192890A patent/CN1476436A/zh active Pending
- 2001-11-12 WO PCT/EP2001/013068 patent/WO2002042277A1/en active IP Right Grant
- 2001-11-12 HU HU0303007A patent/HUP0303007A2/hu unknown
- 2001-11-12 SK SK760-2003A patent/SK7602003A3/sk unknown
- 2001-11-12 EP EP01990405A patent/EP1339692A1/en not_active Withdrawn
- 2001-11-12 RU RU2003117468/04A patent/RU2265016C2/ru not_active IP Right Cessation
- 2001-11-12 KR KR10-2003-7006907A patent/KR20030060953A/ko not_active Application Discontinuation
- 2001-11-12 CZ CZ20031667A patent/CZ20031667A3/cs unknown
- 2001-11-12 IL IL15557301A patent/IL155573A0/xx unknown
- 2001-11-12 CA CA002428459A patent/CA2428459A1/en not_active Abandoned
- 2001-11-12 PL PL01366704A patent/PL366704A1/xx not_active Application Discontinuation
- 2001-11-12 MX MXPA03004534A patent/MXPA03004534A/es active IP Right Grant
- 2001-11-20 US US09/999,082 patent/US6472404B1/en not_active Expired - Fee Related
- 2001-11-21 GT GT200100233A patent/GT200100233A/es unknown
- 2001-11-21 AR ARP010105431A patent/AR031763A1/es unknown
- 2001-11-21 UY UY27033A patent/UY27033A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533401A patent/PA8533401A1/es unknown
- 2001-11-22 PE PE2001001170A patent/PE20020610A1/es not_active Application Discontinuation
-
2003
- 2003-05-21 NO NO20032290A patent/NO20032290D0/no unknown
- 2003-05-21 EC EC2003004618A patent/ECSP034618A/es unknown
- 2003-05-22 BG BG107839A patent/BG107839A/bg unknown
- 2003-05-22 MA MA27172A patent/MA26966A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NO20032290L (no) | 2003-05-21 |
BG107839A (bg) | 2004-06-30 |
NO20032290D0 (no) | 2003-05-21 |
RU2003117468A (ru) | 2005-01-27 |
BR0115566A (pt) | 2003-09-30 |
MXPA03004534A (es) | 2003-09-10 |
RU2265016C2 (ru) | 2005-11-27 |
GT200100233A (es) | 2002-07-04 |
EP1339692A1 (en) | 2003-09-03 |
AR031763A1 (es) | 2003-10-01 |
CZ20031667A3 (cs) | 2004-01-14 |
PA8533401A1 (es) | 2002-10-31 |
WO2002042277A1 (en) | 2002-05-30 |
CA2428459A1 (en) | 2002-05-30 |
SK7602003A3 (en) | 2004-01-08 |
GB0028483D0 (en) | 2001-01-10 |
MA26966A1 (fr) | 2004-12-20 |
KR20030060953A (ko) | 2003-07-16 |
AU2954602A (en) | 2002-06-03 |
PE20020610A1 (es) | 2002-07-13 |
ECSP034618A (es) | 2003-06-25 |
JP2004520283A (ja) | 2004-07-08 |
CN1476436A (zh) | 2004-02-18 |
PL366704A1 (en) | 2005-02-07 |
US6472404B1 (en) | 2002-10-29 |
NZ525550A (en) | 2004-11-26 |
IL155573A0 (en) | 2003-11-23 |
AU2002229546B2 (en) | 2006-05-04 |
UY27033A1 (es) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2423103A1 (en) | N-acylsulfonamide apoptosis promoters | |
HUP0302264A2 (hu) | Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP0303037A2 (hu) | Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
HUP0301113A2 (hu) | Pirrolidinszármazékok, mint ciklusos amp-specifikus foszfodiészteráz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
RS52397B (en) | PYRIDO / 2,1-A / ISOCHINOLINE DERIVATIVES AS DPP-IV INHIBITORS | |
HUP9904363A2 (hu) | Muszkarin antagonista piperidin-éterek és az ezeket tartalmazó gyógyszerkészítmények | |
FR2805810B1 (fr) | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation | |
RU2002125860A (ru) | Новые производные циклического амида | |
ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
HUP0302380A2 (hu) | Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
MX2009006878A (es) | Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas. | |
EA200600364A1 (ru) | Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора | |
HRP20090533T1 (en) | Indolyl derivatives as liver-x-receptor modulators | |
CO6251260A2 (es) | Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c. | |
BRPI0506918A (pt) | derivados de tipo ariloxialquilcarbamatos, sua preparação e sua aplicação terapêutica | |
ATE476431T1 (de) | Piperidin- und azetidinderivate als glyt1- inhibitoren | |
MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
TW200616636A (en) | Novel compounds | |
ATE271868T1 (de) | Neue cathechole als antimikrobielle mittel | |
DE602004026071D1 (de) | Aminopyrone und ihre verwendung als atm inhibitoren | |
ATE429429T1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
HUP9900501A2 (hu) | Muszkarin receptor antagonista hatású oxa- és tiadiazolszármazékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
HUP0303007A2 (hu) | Új vegyületek HIV proteáz inhibitorként történő felhasználásra és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE504592T1 (de) | Trehaloseverbindung und arzneimittel mit der verbindung | |
HUP0202249A2 (hu) | Neurotrop pirrolidin-és piperidin-származékok, ezeket tartalmazó gyógyszerkészítmények és a vegyületek alkalmazása |